HEADER CATALYTIC ANTIBODY 07-JUN-97 1HYX OBSLTE 20-JUN-06 1HYX 2DQT TITLE HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE TITLE 2 HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN 6D9; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB FRAGMENT; COMPND 5 SYNONYM: CATALYTIC ANTIBODY 6D9; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: IMMUNOGLOBULIN 6D9; COMPND 8 CHAIN: H; COMPND 9 FRAGMENT: FAB FRAGMENT; COMPND 10 SYNONYM: CATALYTIC ANTIBODY 6D9 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 CELL_LINE: 6D9 MURINE-MURINE HYBRIDOMA; SOURCE 5 SECRETION: ASCITES FLUID; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 8 ORGANISM_COMMON: MOUSE; SOURCE 9 CELL_LINE: 6D9 MURINE-MURINE HYBRIDOMA; SOURCE 10 SECRETION: ASCITES FLUID KEYWDS CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, KEYWDS 2 IMMUNOGLOBULIN EXPDTA X-RAY DIFFRACTION AUTHOR O.KRISTENSEN,D.G.VASSYLYEV,F.TANAKA,K.MORIKAWA,I.FUJII REVDAT 2 18-MAR-98 1HYX 1 REMARK CRYST1 SCALE REVDAT 1 10-DEC-97 1HYX 0 JRNL AUTH O.KRISTENSEN,D.G.VASSYLYEV,F.TANAKA,K.MORIKAWA, JRNL AUTH 2 I.FUJII JRNL TITL A STRUCTURAL BASIS FOR TRANSITION-STATE JRNL TITL 2 STABILIZATION IN ANTIBODY-CATALYZED HYDROLYSIS: JRNL TITL 3 CRYSTAL STRUCTURES OF AN ABZYME AT 1. 8 A JRNL TITL 4 RESOLUTION. JRNL REF J.MOL.BIOL. V. 281 501 1998 JRNL REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.MIYASHITA,T.HARA,R.TANIMURA,S.FUKUYAMA,C.CAGNON, REMARK 1 AUTH 2 A.KOHARA,I.FUJII REMARK 1 TITL SITE-DIRECTED MUTAGENESIS OF ACTIVE SITE CONTACT REMARK 1 TITL 2 RESIDUES IN A HYDROLYTIC ABZYME: EVIDENCE FOR AN REMARK 1 TITL 3 ESSENTIAL HISTIDINE INVOLVED IN TRANSITION STATE REMARK 1 TITL 4 STABILIZATION REMARK 1 REF J.MOL.BIOL. V. 267 1247 1997 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH I.FUJII,F.TANAKA,H.MIYASHITA,R.TANIMURA,K.KINOSHITA REMARK 1 TITL CORRELATION BETWEEN ANTIGEN-COMBINING SITE REMARK 1 TITL 2 STRUCTURES AND FUNCTIONS WITHIN A PANEL OF REMARK 1 TITL 3 CATALYTIC ANTIBODIES GENERATED AGAINST A SINGLE REMARK 1 TITL 4 TRANSITION STATE ANALOG REMARK 1 REF J.AM.CHEM.SOC. V. 117 6199 1995 REMARK 1 REFN ASTM JACSAT US ISSN 0002-7863 REMARK 1 REFERENCE 3 REMARK 1 AUTH O.KRISTENSEN,H.MIYASHITA,D.G.VASSYLYEV,F.TANAKA, REMARK 1 AUTH 2 I.FUJII,K.MORIKAWA REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY ANALYSIS: REMARK 1 TITL 2 TRANSITION STATE COMPLEX OF A CHLORAMPHENICOL REMARK 1 TITL 3 PRODRUG ACTIVATION SPECIFIC CATALYTIC ANTIBODY REMARK 1 REF PROTEIN PEPT.LETT. V. 1 252 1995 REMARK 1 REFN ASTM PPELEN NE ISSN 0929-8665 REMARK 1 REFERENCE 4 REMARK 1 AUTH H.MIYASHITA,T.HARA,R.TANIMURA,F.TANAKA,M.KIKUCHI, REMARK 1 AUTH 2 I.FUJII REMARK 1 TITL A COMMON ANCESTRY FOR MULTIPLE CATALYTIC REMARK 1 TITL 2 ANTIBODIES GENERATED AGAINST A SINGLE REMARK 1 TITL 3 TRANSITION-STATE ANALOG REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 91 6045 1994 REMARK 1 REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 1 REFERENCE 5 REMARK 1 AUTH H.MIYASHITA,T.HARA,R.TANIMURA,F.TANAKA,M.KIKUCHI, REMARK 1 AUTH 2 I.FUJII REMARK 1 TITL ERRATUM. A COMMON ANCESTRY FOR MULTIPLE CATALYTIC REMARK 1 TITL 2 ANTIBODIES GENERATED AGAINST A SINGLE REMARK 1 TITL 3 TRANSITION-STATE ANALOG REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 91 10757 1994 REMARK 1 REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 1 REFERENCE 6 REMARK 1 AUTH H.MIYASHITA,Y.KARAKI,M.KIKUCHI,I.FUJII REMARK 1 TITL PRODRUG ACTIVATION VIA CATALYTIC ANTIBODIES REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 5337 1993 REMARK 1 REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 69.2 REMARK 3 NUMBER OF REFLECTIONS : 27402 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.700 REMARK 3 FREE R VALUE TEST SET COUNT : 3055 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 3 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 45.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5337 REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE : 0.3520 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 642 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3369 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.41 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.38 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 30.69 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.71 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.580 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.710 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.130 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.620 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CPD.PAR REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : CPD.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HYX COMPLIES WITH FORMAT V. 3.0, 1-DEC-2006 REMARK 4 REMARK 4 THIS FILE IS A TEST VERSION. REMARK 4 REMARK 4 THIS IS THE REMEDIATED VERSION OF THIS PDB ENTRY. REMARK 4 REMEDIATED DATA FILE REVISION 3.101 (2007-05-01) REMARK 6 REMARK 6 COORDINATES ARE GIVEN FOR THE REGION H 128 - H 134, REMARK 6 ALTHOUGH THE REGION IS DISORDERED. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : MAY-1994 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 8.30 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : FUJI FILM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : WEIS REMARK 200 DATA SCALING SOFTWARE : PROTEIN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28513 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 6.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 69.0 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 44.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.851 REMARK 200 STARTING MODEL: PDB ENTRY 2IGF REMARK 200 REMARK 200 REMARK: THE MAIN DATA WAS COLLECTED USING THE WEISSENBERG REMARK 200 METHOD, AND MERGED WITH DATA COLLECTED ON A DIP100 DETECTOR AT REMARK 200 A WAVELENGTH OF 1.5418 A. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PRE-FORMED COMPLEX WAS REMARK 280 CRYSTALLIZED FROM 17% PEG 4000,50 MM TRIS, 0.1 MM EDTA, PH 8.3 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.83100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO L 12 CB PRO L 12 CG 0.046 REMARK 500 THR H 68 CB THR H 68 CG2 0.042 REMARK 500 MET H 82 SD MET H 82 CE -0.066 REMARK 500 PRO H 119 CB PRO H 119 CG 0.047 REMARK 500 PRO H 147 CB PRO H 147 CG 0.043 REMARK 500 PRO H 149 CB PRO H 149 CG 0.050 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU L 73 N - CA - C ANGL. DEV. = -9.1 DEGREES REMARK 500 CYS L 88 N - CA - C ANGL. DEV. = -9.8 DEGREES REMARK 500 THR L 114 N - CA - C ANGL. DEV. =-10.8 DEGREES REMARK 500 VAL L 132 N - CA - C ANGL. DEV. = -8.6 DEGREES REMARK 500 ASN L 137 N - CA - C ANGL. DEV. = 9.1 DEGREES REMARK 500 LEU L 160 CA - CB - CG ANGL. DEV. = 9.0 DEGREES REMARK 500 ALA H 33 N - CA - C ANGL. DEV. = -8.8 DEGREES REMARK 500 ILE H 51 N - CA - C ANGL. DEV. =-10.0 DEGREES REMARK 500 LEU H 60 N - CA - C ANGL. DEV. = -9.0 DEGREES REMARK 500 CYS H 92 N - CA - C ANGL. DEV. = -9.0 DEGREES REMARK 500 TYR H 98 N - CA - C ANGL. DEV. = -8.5 DEGREES REMARK 500 SER H 113 N - CA - C ANGL. DEV. = -8.2 DEGREES REMARK 500 LYS H 143 N - CA - C ANGL. DEV. = 8.4 DEGREES REMARK 500 GLY H 144 N - CA - C ANGL. DEV. = 9.0 DEGREES REMARK 500 TRP H 188 N - CA - C ANGL. DEV. = 8.8 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL L 51 -55.39 73.44 REMARK 500 GLN H 131 160.66 57.25 REMARK 500 SER H 156 -38.09 65.43 REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 34 DISTANCE = 13.40 ANGSTROMS REMARK 525 HOH 66 DISTANCE = 6.94 ANGSTROMS REMARK 525 HOH 77 DISTANCE = 5.44 ANGSTROMS REMARK 525 HOH 87 DISTANCE = 7.37 ANGSTROMS REMARK 525 HOH 91 DISTANCE = 6.24 ANGSTROMS REMARK 525 HOH 98 DISTANCE = 7.60 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 CPD 1: THE BOUND HAPTEN IS A SIMPLE DERIVATIVE OF THE REMARK 600 CHLORAMPHENICOL PHOSPHONATE(CPP) USED FOR IMMUNIZATION REMARK 600 (REFERENCE 5). REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR-DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: 1 REMARK 800 SITE_DESCRIPTION: THE SIDE CHAIN OF THIS RESIDUE, FORMS REMARK 800 A SPECIFIC HYDROGEN BOND TO THE TRANSITION-STATE REMARK 800 STRUCTURE DURING CATALYSIS. REMARK 860 REMARK 860 CORRECTION AFTER RELEASE REMARK 860 CORRECT CELL DIMENSIONS. CORRECT SCALE AND REMARKS REMARK 860 ACCORDINGLY. 18-MAR-1998. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 THIS ENTRY IS RELATED TO PDB ENTRY 1HYY. REMARK 999 REMARK 999 SEQUENCE REMARK 999 REFERENCE: THE LIGHT CHAIN CONSTANT REGION HAS BEEN REMARK 999 SEQUENCED (FUJII ET AL., UNPUBLISHED). IT IS IDENTICAL REMARK 999 TO E.G. THE GENBANK ENTRY (ACCESSION NUMBER X79906), ALSO REMARK 999 REPRESENTING A KAPPA LIGHT CHAIN. A DISCREPANCY EXISTS REMARK 999 FOR RESIDUE H 1, I.E. EITHER GLU OR GLN. THE HEAVY CHAIN REMARK 999 CONSTANT REGION HAS BEEN SEQUENCED (FUJII ET AL., REMARK 999 UNPUBLISHED). IT IS IDENTICAL TO E.G. THE GENBANK ENTRY REMARK 999 (ACCESSION NUMBER U00927), ALSO OF THE GAMMA CLASS. DBREF 1HYX L 3 211 PIR S52028 S52028 3 216 SEQADV 1HYX THR L 7 PIR S52028 SER 7 CONFLICT SEQADV 1HYX THR L 27A PIR S52028 SER 28 CONFLICT SEQADV 1HYX ASP L 30 PIR S52028 ASN 35 CONFLICT SEQADV 1HYX ASP L 34 PIR S52028 GLU 39 CONFLICT SEQADV 1HYX PHE L 36 PIR S52028 TYR 41 CONFLICT SEQADV 1HYX LYS L 103 PIR S52028 ASN 108 CONFLICT SEQRES 1 L 216 GLU LEU VAL MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 L 216 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 216 GLN THR ILE VAL HIS SER ASN GLY ASP THR TYR LEU ASP SEQRES 4 L 216 TRP PHE LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 L 216 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 L 216 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 216 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 L 216 TYR CYS PHE GLN GLY SER HIS VAL PRO PRO THR PHE GLY SEQRES 9 L 216 GLY GLY THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA SEQRES 10 L 216 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 L 216 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 L 216 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 L 216 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 L 216 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 L 216 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 L 216 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 L 216 PRO ILE VAL LYS SER PHE ASN ARG SEQRES 1 H 224 GLU VAL LYS LEU LEU GLU SER GLY GLY GLY LEU VAL LYS SEQRES 2 H 224 PRO GLY GLY SER LEU LYS LEU SER CYS ALA ALA SER GLY SEQRES 3 H 224 PHE THR PHE SER ASN TYR ALA MET SER TRP VAL ARG GLN SEQRES 4 H 224 THR PRO GLU LYS ARG LEU GLU TRP VAL VAL SER ILE SER SEQRES 5 H 224 SER GLY GLY SER ILE TYR TYR LEU ASP SER VAL LYS GLY SEQRES 6 H 224 ARG PHE THR VAL SER ARG ASP ASN ALA ARG ASN ILE LEU SEQRES 7 H 224 TYR LEU GLN MET THR SER LEU ARG SER GLU ASP THR ALA SEQRES 8 H 224 MET TYR PHE CYS ALA ARG VAL SER HIS TYR ASP GLY SER SEQRES 9 H 224 ARG ASP TRP TYR PHE ASP VAL TRP GLY ALA GLY THR SER SEQRES 10 H 224 VAL THR VAL SER SER ALA LYS THR THR PRO PRO SER VAL SEQRES 11 H 224 TYR PRO LEU ALA PRO GLY SER ALA ALA GLN THR ASN SER SEQRES 12 H 224 MET VAL THR LEU GLY CYS LEU VAL LYS GLY TYR PHE PRO SEQRES 13 H 224 GLU PRO VAL THR VAL THR TRP ASN SER GLY SER LEU SER SEQRES 14 H 224 SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER ASP SEQRES 15 H 224 LEU TYR THR LEU SER SER SER VAL THR VAL PRO SER SER SEQRES 16 H 224 THR TRP PRO SER GLU THR VAL THR CYS ASN VAL ALA HIS SEQRES 17 H 224 PRO ALA SER SER THR LYS VAL ASP LYS LYS ILE VAL PRO SEQRES 18 H 224 ARG ASP CYS HET CPD 1 48 HETNAM CPD [1-(3-DIMETHYLAMINO-PROPYL)-3-ETHYL-UREIDO]-[4-(2,2,2- HETNAM 2 CPD TRIFLUORO-ACETYLAMINO)-BENZYL]PHOSPHINIC ACID-2-(2,2- HETNAM 3 CPD DIHYDRO-ACETYLAMINO)-3-HYDROXY-1-(4-NITROPHENYL)- HETNAM 4 CPD PROPYL ESTER FORMUL 3 CPD C28 H36 CL2 F3 N6 O8 P FORMUL 4 HOH *140(H2 O) HELIX 1 1 ALA L 80 ASP L 82 5 3 HELIX 2 2 SER L 122 SER L 127 1 6 HELIX 3 3 LYS L 183 ARG L 188 1 6 HELIX 4 4 PHE H 29 ASN H 31 5 3 HELIX 5 5 SER H 84 ASP H 86 5 3 HELIX 6 6 PRO H 200 SER H 202 5 3 SHEET 1 A 4 MET L 4 THR L 7 0 SHEET 2 A 4 ALA L 19 SER L 25 -1 N ARG L 24 O THR L 5 SHEET 3 A 4 ASP L 70 ILE L 75 -1 N ILE L 75 O ALA L 19 SHEET 4 A 4 PHE L 62 SER L 67 -1 N SER L 67 O ASP L 70 SHEET 1 B 2 SER L 10 VAL L 13 0 SHEET 2 B 2 LYS L 103 ILE L 106 1 N LYS L 103 O LEU L 11 SHEET 1 C 3 VAL L 85 GLN L 90 0 SHEET 2 C 3 LEU L 33 GLN L 38 -1 N GLN L 38 O VAL L 85 SHEET 3 C 3 LYS L 45 ILE L 48 -1 N ILE L 48 O TRP L 35 SHEET 1 D 4 THR L 114 PHE L 118 0 SHEET 2 D 4 GLY L 129 ASN L 137 -1 N ASN L 137 O THR L 114 SHEET 3 D 4 MET L 175 THR L 182 -1 N LEU L 181 O ALA L 130 SHEET 4 D 4 VAL L 159 TRP L 163 -1 N SER L 162 O SER L 176 SHEET 1 E 3 ASN L 145 ILE L 150 0 SHEET 2 E 3 SER L 191 THR L 197 -1 N THR L 197 O ASN L 145 SHEET 3 E 3 ILE L 205 ASN L 210 -1 N PHE L 209 O TYR L 192 SHEET 1 F 4 LYS H 3 SER H 7 0 SHEET 2 F 4 LEU H 18 SER H 25 -1 N SER H 25 O LYS H 3 SHEET 3 F 4 ILE H 77 MET H 82 -1 N MET H 82 O LEU H 18 SHEET 4 F 4 PHE H 67 ASP H 72 -1 N ASP H 72 O ILE H 77 SHEET 1 G 5 THR H 107 VAL H 109 0 SHEET 2 G 5 ALA H 88 VAL H 95 -1 N TYR H 90 O THR H 107 SHEET 3 G 5 ALA H 33 GLN H 39 -1 N GLN H 39 O MET H 89 SHEET 4 G 5 LEU H 45 ILE H 51 -1 N ILE H 51 O MET H 34 SHEET 5 G 5 ILE H 57 TYR H 59 -1 N TYR H 58 O SER H 50 SHEET 1 H 4 SER H 120 LEU H 124 0 SHEET 2 H 4 MET H 135 LYS H 143 -1 N LYS H 143 O SER H 120 SHEET 3 H 4 LEU H 177 PRO H 184 -1 N VAL H 183 O VAL H 136 SHEET 4 H 4 VAL H 163 THR H 165 -1 N HIS H 164 O SER H 180 SHEET 1 I 3 THR H 151 TRP H 154 0 SHEET 2 I 3 THR H 194 ALA H 198 -1 N ALA H 198 O THR H 151 SHEET 3 I 3 ASP H 207 LYS H 209 -1 N LYS H 208 O CYS H 195 SHEET 1 J 2 VAL H 169 GLN H 171 0 SHEET 2 J 2 LEU H 174 THR H 176 -1 N THR H 176 O VAL H 169 SHEET 1 K 2 ALA H 93 VAL H 95 0 SHEET 2 K 2 PHE H 100K TRP H 103 -1 N VAL H 102 O ARG H 94 SSBOND 1 CYS L 23 CYS L 88 SSBOND 2 CYS L 134 CYS L 194 SSBOND 3 CYS H 22 CYS H 92 SSBOND 4 CYS H 140 CYS H 195 CISPEP 1 THR L 7 PRO L 8 0 -0.21 CISPEP 2 VAL L 94 PRO L 95 0 0.06 CISPEP 3 TYR L 140 PRO L 141 0 0.09 CISPEP 4 PHE H 146 PRO H 147 0 -0.20 CISPEP 5 GLU H 148 PRO H 149 0 -0.22 CRYST1 55.906 61.662 66.673 90.00 104.68 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017887 0.000000 0.004686 0.00000 SCALE2 0.000000 0.016217 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015505 0.00000